Osteogenesis imperfecta: the audiological phenotype lacks correlation with the genotype

被引:40
|
作者
Swinnen, Freya K. R. [1 ]
Coucke, Paul J. [2 ]
De Paepe, Anne M. [2 ]
Symoens, Sofie [2 ]
Malfait, Fransiska [2 ]
Gentile, Filomena V. [3 ]
Sangiorgi, Luca [3 ]
D'Eufemia, Patrizia [4 ]
Celli, Mauro [4 ]
Garretsen, Ton J. T. M. [5 ]
Cremers, Cor W. R. J. [6 ]
Dhooge, Ingeborg J. M. [1 ]
De Leenheer, Els M. R. [1 ]
机构
[1] Ghent Univ Hosp, Dept Otorhinolaryngol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium
[3] Rizzoli Orthopaed Inst, Dept Med Genet & Rare Orthopaed Dis, I-40136 Bologna, Italy
[4] Univ Roma La Sapienza, Dept Pediat, I-00161 Rome, Italy
[5] Med Ctr Alkmaar, Dept Otorhinolaryngol, NL-1815 JD Alkmaar, Netherlands
[6] Radboud Univ Nijmegen, FC Donders Inst Neurosci, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands
关键词
Osteogenesis Imperfecta; COL1A1; COL1A2; hearing loss; genotype-phenotype correlation; HEARING-LOSS; MUTATION;
D O I
10.1186/1750-1172-6-88
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Osteogenesis Imperfecta (OI) is a heritable connective tissue disorder mainly caused by mutations in the genes COL1A1 and COL1A2 and is associated with hearing loss in approximately half of the cases. The hearing impairment usually starts between the second and fourth decade of life as a conductive hearing loss, frequently evolving to mixed hearing loss thereafter. A minority of patients develop pure sensorineural hearing loss. The interindividual variability in the audiological characteristics of the hearing loss is unexplained. Methods: With the purpose of evaluating inter-and intrafamilial variability, hearing was thorougly examined in 184 OI patients (type I: 154; type III: 4; type IV: 26), aged 3-89 years, with a mutation in either COL1A1 or COL1A2 and originating from 89 different families. Due to the adult onset of hearing loss in OI, correlations between the presence and/or characteristics of the hearing loss and the underlying mutation were investigated in a subsample of 114 OI patients from 64 different families who were older than 40 years of age or had developed hearing loss before the age of 40. Results: Hearing loss was diagnosed in 48.4% of the total sample of OI ears with increasing prevalence in the older age groups. The predominant type was a mixed hearing loss (27.5%). A minority presented a pure conductive (8.4%) or pure sensorineural (12.5%) loss. In the subsample of 114 OI subjects, no association was found between the nature of the mutation in COL1A1 or COL1A2 genes and the occurrence, type or severity of hearing loss. Relatives originating from the same family differed in audiological features, which may partially be attributed to their dissimilar age. Conclusions: Our study confirms that hearing loss in OI shows a strong intrafamilial variability. Additional modifications in other genes are assumed to be responsible for the expression of hearing loss in OI.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Osteogenesis imperfecta caused by PPIB mutation with severe phenotype and congenital hearing loss
    Rush, Eric T.
    Caldwell, Kathleen S.
    Kreikemeier, Rose M.
    Lutz, Richard E.
    Esposito, Paul W.
    JOURNAL OF PEDIATRIC GENETICS, 2014, 3 (01) : 29 - 34
  • [22] Genotype-Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease
    Shi, Jingru
    Ren, Meng
    Jia, Jinmeng
    Tang, Muxue
    Guo, Yongli
    Ni, Xin
    Shi, Tieliu
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [23] Genotype-Phenotype Relationship and Follow-up Analysis of a Chinese Cohort With Osteogenesis Imperfecta
    Wei, Shuoshuo
    Yao, Yangyang
    Shu, Meng
    Gao, Ling
    Zhao, Jiajun
    Li, Tianyou
    Wang, Yanzhou
    Xu, Chao
    ENDOCRINE PRACTICE, 2022, 28 (08) : 760 - 766
  • [24] Metabolic phenotype in the mouse model of osteogenesis imperfecta
    Boraschi-Diaz, Iris
    Tauer, Josephine T.
    El-Rifai, Omar
    Guillemette, Delphine
    Lefebvre, Genevieve
    Rauch, Frank
    Ferron, Mathieu
    Komarova, Svetlana V.
    JOURNAL OF ENDOCRINOLOGY, 2017, 234 (03) : 279 - 289
  • [25] Osteogenesis imperfecta type XVII: expansion of the phenotype
    Brooke M. Dunleavy
    Alison J. Schildt
    Caitlin Harrington
    David A. Stevenson
    Egyptian Journal of Medical Human Genetics, 25
  • [26] Osteogenesis imperfecta type XVII: expansion of the phenotype
    Dunleavy, Brooke M.
    Schildt, Alison J.
    Harrington, Caitlin
    Stevenson, David A.
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2024, 25 (01)
  • [27] Establishing Genotype-phenotype Correlation in USH2A-related Disorders to Personalize Audiological Surveillance and Rehabilitation
    Molina-Ramirez, Leslie P.
    Lenassi, Eva
    Ellingford, Jamie M.
    Sergouniotis, Panagiotis I.
    Ramsden, Simon C.
    Bruce, Iain A.
    Black, Graeme C. M.
    OTOLOGY & NEUROTOLOGY, 2020, 41 (04) : 431 - 437
  • [28] Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
    Choi, Yunha
    Hwang, Soojin
    Kim, Gu-Hwan
    Lee, Beom Hee
    Yoo, Han-Wook
    Choi, Jin-Ho
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 27 (01) : 22 - 29
  • [29] Stapedotomy in osteogenesis imperfecta patients
    Ferekidis, E
    Stavroulaki, P
    Vossinakis, I
    Yiotakis, J
    Manolopoulos, L
    Adamopoulos, G
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2000, 114 (06) : 424 - 428
  • [30] Osteogenesis imperfecta
    Herreros, M. B.
    Franco, R.
    Ascurra, M.
    PEDIATRIA-ASUNCION, 2008, 35 (01): : 33 - 37